In-vitro and in-vivo studies of two-drug cocktail therapy targeting chemobrain via the Nrf2/NF-κB signaling pathway.

Autor: Singh A; Department of Pharmacology, ISF College of Pharmacy affiliated to I.K Gujral Punjab Technical University, Jalandhar, 142001, Punjab, India. artiniper@gmail.com.; Department of Pharmaceutical Sciences, School of Health Science & Technology, UPES, Dehradun, India. artiniper@gmail.com., Kumar V; Department of Pharmacology, ISF College of Pharmacy affiliated to I.K Gujral Punjab Technical University, Jalandhar, 142001, Punjab, India., Langeh U; Department of Pharmacology, ISF College of Pharmacy affiliated to I.K Gujral Punjab Technical University, Jalandhar, 142001, Punjab, India., Kapil L; Department of Pharmacology, ISF College of Pharmacy affiliated to I.K Gujral Punjab Technical University, Jalandhar, 142001, Punjab, India., Kaur S; Department of Pharmacology, ISF College of Pharmacy affiliated to I.K Gujral Punjab Technical University, Jalandhar, 142001, Punjab, India.; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad, Hyderabad, 500037, Telangana, India., Rana N; Department of Pharmacology, ISF College of Pharmacy affiliated to I.K Gujral Punjab Technical University, Jalandhar, 142001, Punjab, India., Bhattacharya A; Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, 142001, Punjab, India., Singh R; Department of Pharmacognosy, ISF College of Pharmacy, Moga, 142001, India., Bhatti JS; Department of Human Genetics and Molecular Medicine, Central University of Punjab, Bathinda, 151401, Punjab, India., Singh C; Department of Pharmaceutical Sciences, HNB Garhwal University (A Central University), Chauras Campus, Distt. Tehri Garhwal, Uttarakhand, 246174, India.
Jazyk: angličtina
Zdroj: Journal of molecular histology [J Mol Histol] 2024 Aug; Vol. 55 (4), pp. 599-625. Date of Electronic Publication: 2024 Jul 23.
DOI: 10.1007/s10735-024-10217-1
Abstrakt: Today, we critically need alternative therapeutic options for chemotherapy-induced cognitive impairment (CICI), often known as chemo brain. Mitochondrial dysfunction and oxidative stress are two of the primary processes that contribute to the development of chemobrain. Therefore, the purpose of this study was to investigate how CoQ10 and berberine shield neurons from chemotherapy-induced damage in in-vitro studies and memory loss in vivo studies. For the in-vitro investigation, we employed SH-SY5Y cell lines, and for the in-vivo study, we used female Swiss albino mice divided into seven different groups. Data from in-vitro studies revealed that treatment with coenzyme Q10 (CoQ10) and berberine improved chemotherapy-induced toxicity by reducing mitochondrial and total cellular ROS, as well as apoptosis-elicited markers (caspase 3 and 9). CoQ10 and berberine therapy inhibited the nuclear translocation of NF-κB and, consequently, the subsequent expressions of NLRP3 and IL-1β, implying the prevention of inflammasome formation. Furthermore, CoQ10 and berberine therapy boosted Nrf2 levels. This is a regulator for cellular resistance to oxidants. The in vivo results showed that treatment with CoQ10 (40 mg/kg) and berberine (200 mg/kg) improved the behavioral alterations induced by CAF (40/4/25 mg/kg) in both the Morris Water Maze (MWM) and Novel Object Recognition (NOR) tests. Furthermore, biochemical and molecular evidence revealed the antioxidant, mitochondrial restorative, and anti-inflammatory potential of CoQ10 (40 mg/kg) and berberine (200 mg/kg) against CAF (40/4/25 mg/kg) subjected mice. In addition, the histological analysis using H&E staining and transmission electron microscopy (for mitochondrial morphology) showed that mice treated with the cocktails had an increased number of healthy neurons with intact mitochondria and a reduced presence of autophagic vacuoles in the hippocampal region of the brain. These findings back up our theory about this novel cocktail method for CAF-induced cognitive impairment.
(© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
Databáze: MEDLINE
Externí odkaz: